No Data
No Data
Mesa Laboratories, Inc. to Announce Third Quarter Fiscal Year 2025 Financial Results on February 4, 2025
Wells Fargo Maintains Mesa Laboratories(MLAB.US) With Sell Rating, Maintains Target Price $120
Wells Fargo Keeps Their Sell Rating on Mesa Laboratories (MLAB)
Is There An Opportunity With Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 22% Undervaluation?
Mesa Laboratories To Go Ex-Dividend On February 28th, 2025 With 0.16 USD Dividend Per Share
Mesa Laboratories Keeps Quarterly Dividend at $0.16 Per Share, Payable March 17 to Shareholders of Record on Feb. 28